%PDF-1.7
%
1 0 obj
<>stream
application/pdf20209 - 01GAVAGEPentabromodiphenyl oxide (technical) (DE 71)RATS90-DAYP05: INCIDENCE RATES OF NEOPLASMS BY ANATOMIC SITE (SYSTEMIC LESIONS ABRIDGED) (a)ENTDMSE
endstream
endobj
2 0 obj
<>/Type/StructTreeRoot/K[3 0 R]/ParentTree 4 0 R>>
endobj
3 0 obj
<>
endobj
4 0 obj
<>
endobj
5 0 obj
<>
endobj
6 0 obj
<>
endobj
7 0 obj
<>
endobj
8 0 obj
<>
endobj
9 0 obj
<>
endobj
10 0 obj
<>
endobj
11 0 obj
<>
endobj
12 0 obj
<>
endobj
13 0 obj
<>
endobj
14 0 obj
<>
endobj
15 0 obj
<>
endobj
16 0 obj
<>
endobj
17 0 obj
<>
endobj
18 0 obj
<>
endobj
19 0 obj
<>
endobj
20 0 obj
<>
endobj
21 0 obj
<>
endobj
22 0 obj
<>
endobj
23 0 obj
<>
endobj
24 0 obj
<>
endobj
25 0 obj
<>
endobj
26 0 obj
<>
endobj
27 0 obj
<>
endobj
28 0 obj
<>
endobj
29 0 obj
<>
endobj
30 0 obj
<>
endobj
31 0 obj
<>
endobj
32 0 obj
<>
endobj
33 0 obj
<>
endobj
34 0 obj
<>
endobj
35 0 obj
<>
endobj
36 0 obj
<>
endobj
37 0 obj
<>
endobj
38 0 obj
<>
endobj
39 0 obj
<>
endobj
40 0 obj
<>
endobj
41 0 obj
<>
endobj
42 0 obj
<>
endobj
43 0 obj
<>
endobj
44 0 obj
<>
endobj
54 0 obj
<>>>/MediaBox[0 0 612 792]/StructParents 0/Rotate 90>>
endobj
63 0 obj
<>
endobj
64 0 obj
<>stream
x]o@e{! `&(h(Z!41iζ*MwF2B9g3G`a@DŽ}o_e)
!}Gʝ-F[z#fc?vE!8`"W16JK}U7~O.l᠋ ZBXO44lSEmDAhm]HA6Q~');5Y^\Tec!K#rv$g ]cVq_pw6Sj9u)&VOԥSwrrcT+,g_WZAue+w'zQ-"}F4.4-`gñVCLAp;t^p9#'4ݶfŋ\;H98!4?&YB^|]E*Q#BX^@pt
,N=j("\N/y]O9;<9o0|>EpiMXD +7CX!˙C>b>A8|X_ag~8]!6Q-L|_ԛHGP'c{ǂn[8f.@~